Awareness, treatment and control of hyperlipidaemia, hypertension and diabetes mellitus in a selected population of southern Italy.
The purpose of the present study was to assess the degree of awareness, treatment and control of hyperlipidaemia compared with hypertension and diabetes mellitus in a selected population of southern Italy.
All participants to a cardiovascular disease prevention campaign examined between April 1994 and July 1995 were screened for hyperlipidaemia, hypertension and diabetes mellitus.
Subjects received also ECG, echo-Doppler of carotid arteries and filled in a questionnaire concerning personal and familial cardiovascular diseases, smoking habit and drug consumption.
Of the 742 participants, 327 were found to have hypertension, 73 to have diabetes mellitus, 287 to have mild hyperlipidaemia and 322 to have moderate-severe hyperlipidaemia.
Among hypertensive subjects, 60.2% were aware of their condition, 53.5% were treated and 15.6% had their blood pressure controlled at the recommended level (<140/90 mmHg).
Among diabetic subjects, 76.7% were aware, 64.4% treated and 19.2% reached fasting blood glucose level of less than 7.77 mmol/l (140 mg/dl).
Only 24.0% of subjects with mild hyperlipidaemia were aware of their condition.
Of the subjects found to have moderate-severe hyperlipidaemia, 64.9% were aware, 32.3% were treated and 9.0% had plasma cholesterol and triglycerides concentration of less than 6.45 and 5.65 mmol/l (250 and 500 mg/dl), respectively (cutoffs chosen to separate mild from moderate-severe hyperlipidaemia). (...)
Mots-clés Pascal : Hyperlipémie, Hypertension artérielle, Diabète, Chimiothérapie, Traitement, Prise conscience, Programme sanitaire, Etude comparative, Prévalence, Homme, Prévention, Epidémiologie, Lipide, Italie, Europe, Métabolisme pathologie, Dyslipémie, Appareil circulatoire pathologie, Endocrinopathie
Mots-clés Pascal anglais : Hyperlipemia, Hypertension, Diabetes mellitus, Chemotherapy, Treatment, Awareness, Sanitary program, Comparative study, Prevalence, Human, Prevention, Epidemiology, Lipids, Italy, Europe, Metabolic diseases, Dyslipemia, Cardiovascular disease, Endocrinopathy
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0432265
Code Inist : 002B30A03C. Création : 19/12/1997.